Singapore markets closed

Merck & Co., Inc. (MRK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
102.95-1.35 (-1.29%)
At close: 04:01PM EDT
102.70 -0.25 (-0.24%)
Pre-market: 09:01AM EDT

Merck & Co., Inc.

126 East Lincoln Avenue
Rahway, NJ 07065
United States
908 740 4000

IndustryDrug Manufacturers—General
Full-time employees67,000

Key executives

NameTitlePayExercisedYear born
Mr. Robert M. Davis J.D.Chairman, Pres & CEO6.08M6.77M1967
Ms. Caroline LitchfieldExec. VP & CFO2.8MN/A1969
Ms. Jennifer L. ZacharyExec. VP & Gen. Counsel2.73M3.46M1978
Dr. Dean Y. Li M.D., Ph.D.Exec. VP & Pres of Merck Research Laboratories3.44MN/A1962
Mr. Chirfi GuindoSr. VP & Chief Marketing Officer for Merck Human Health1.54MN/A1966
Mr. David Michael WilliamsExec. VP and Chief Information & Digital OfficerN/AN/A1969
Mr. Peter DannenbaumVP of Investor RelationsN/AN/AN/A
Lisa LeCointe-CephasSr. VP and Chief Ethics & Compliance OfficerN/AN/A1982
Ms. Cristal N. DowningExec. VP and Chief Communications & Public Affairs OfficerN/AN/A1970
Mr. Steven C. MizellExec. VP & Chief HR OfficerN/AN/A1960
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. It has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics LP; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV, as well as collaboration with Bionomics to identify novel a7 nAChR PAMs suitable for the treatment of cognitive disorder. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.

Corporate governance

Merck & Co., Inc.’s ISS governance QualityScore as of 28 September 2023 is 3. The pillar scores are Audit: 5; Board: 4; Shareholder rights: 3; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.